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In rat liver, the activity of 6-phosphofructo-2-kinase (PFK-2) decreases upon starvation and in diabetes. Cyclic AMP- 
dependent phosphorylation of the enzyme is not sufficient to account for this decrease. PFK-2 content was therefore 
measured by immunotitration and relative PFK-2 mRNA levels were determined by hybridization with cDNA probes. 
The data are compatible with a posttranscriptional mechanism of regulation that involves decreased translational efficien- 
cy of PFK-2 mRNA.and(or) increased turnover of the PFK-2 protein. 
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1. INTRODUCTION 
Fructose 2,6-bisphosphate is an intracellular 
regulatory molecu!e that controls glycolysis in 
mammalian tissues by integrating hormonal and 
metabolic signals [ 11. These signals act through 
6-phosphofructo-2-kinase (EC 2.7.1.105) and 
fructose-2,6_bisphosphatase (EC 3.1.3.46), which 
respectively catalyze the synthesis and degradation 
of Fru-2,6-Pz. The two activities are borne by the 
same polypeptide chain. Although phosphoryla- 
tion of the liver bifunctional enzyme can influence 
its activities, little is known of additional 
regulatory mechanisms uch as transcriptional and 
translational control. The existence of 
PFK-2/FBPase-2 isozymes [l] complicates the 
problem. 
To approach these questions, we have prepared 
antibody and cDNA probes for PFK-2 [2]. Rat 
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liver was chosen as a model because PFK-2/FBP- 
ase-2 activity decreases [3-51 during starvation or 
diabetes. Glucagon-activated phosphorylation of 
the bifunctional enzyme by CAMP-dependent pro- 
tein kinase does not fully account for the decrease 
in PFK-2 activity seen under these conditions [6]. 
We have therefore determined whether PFK-2 en- 
zyme content changed in the liver of starved or 
diabetic rats and, if so, whether this was correlated 
with changes in PFK-2 mRNA levels. 
2. EXPERIMENTAL 
All reagents were of the best grade commercially available. 
Male Wistar rats (200-250 g) on a standard Purina chow diet 
were rendered diabetic by a single i.v. injection of alloxan 
(60 mg/kg) or streptozotocin (55 mg/kg) respectively 72 h or 2 
weeks before being killed. The diabetic state was assessed by a 
positive urine strip test (Ames) for glucose (> 15 mM). This test 
was also positive for acetoacetate (> 1.5 mM) in the alloxan- 
treated diabetic rats. Other rats were deprived of food 72 h 
before being killed. Normally fed rats served as controls. After 
decapitation, the liver was frozen in liquid N2. For biochemical 
determinations, liver was homogenized (Potter) in 3 vols of an 
ice-cold solution containing 50 mM KCI, 2 mM EDTA, 5 mM 
MgC12, 15 mM fl-mercaptoethanol, 0.1 mM phenylmethylsul- 
fonyl fluoride, Trasylol (16 yg/ml), leupeptin (8 pg/ml), 
20 mM Hepes and 1 mM phosphate, pH 7.0. PFK-2 activity 
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was measured either on a supernate (10000 x g, 20 min) frac- 
tionated by 6-20% polyethylene glycol (PEG extract) or on a 
cytosol (105000 x g, 60 min). Unless mentioned otherwise, the 
assay was performed at pH 8.5 to measure the ‘total’ activity, 
which is insensitive to the phosphorylation state of the enzyme 
171. Pyruvate kinase activity, measured at 5 mM 
phosphoenolpyruvate [S], and protein concentration [9] were 
determined as described. Total RNA was prepared from tissue 
homogenized in a Waring Blendor (full speed, 60 s), either by 
the LiCl/urea method [lo] or by a modified [l l] guanidinium 
thiocyanate [I21 method. Results obtained by either technique 
were identical. Glycogen contaminating RNA from fed rats was 
pelleted by ultracentrifugation (55000 x g, 30 min) of the final 
ethanol precipitate of RNA resuspended in water. Poly(A)+ 
RNA was isolated by oligo(dT) chromatography [13]. 
RNA-cDNA hybridization after formaldehyde/formamide 
denaturation was studied by the Northern [14] and dot blot [15] 
techniques, using rat liver PFK-2 cDNA probes labeled with 
[cu-32P]dCTP by nick translation or by the multiprime system 
(Amersham). Chicken p-actin and rat liver L-type pyruvate 
kinase cDNA probes were also used as controls in the dot blot 
hybridization experiments. Liver PFK-2 is a dimer of two iden- 
tical 470-amino acid polypeptides. The RL2K-8 PFK-2 cDNA 
probe (1086 bp) corresponds to the last 304 amino acids of 
PFK-2 plus 174 nucleotides of the 3 ‘-untranslated sequence [2]. 
Probe RL2K-22~2 corresponds to the first 90 amino acids of 
PFK-2 plus 173 nucleotides of the 5’-untranslated sequence. 
Probe RL2K-4~3 is identical to RL2K-22~2, but for the fact that 
it is 104 bp shorter at the 5’-end. For the dot blot mRNA 
assays, nitrocellulose filters were prehybridized for 5 h at 42°C 
in a phosphate buffer (50 mM, pH 6.8) containing 50% for- 
mamide, salmon sperm DNA (lOOpg/ml), and 5 x SSC and 5 
x Denhardt solutions. 1 x Denhardt is 0.02% each of bovine 
serum albumin, polyvinylpyrrolidone and Ficoll. 1 x SSC is 
0.15 M NaCl and 0.015 M sodium citrate. Hybridization 
(42°C 16 h) was performed in a 20 mM phosphate buffer sup- 
plemented as above. Filters were then washed for 15 min at 
room temperature in 2 x SSC + 0.1% SDS, then for 30 min at 
50°C in 0.1 x SSC + 0.1% SDS. 
To obtain antibodies against native PFK-2, rabbits were im- 
munized with PFK-2 purified [16] from chicken liver. An- 
tiserum BCL-2 gave a positive ELISA signal at a 10e6 dilution 
with purified rat liver PFK-2. 1 ,uI of this antiserum precipitated 
5 pU of rat liver PFK-2 activity. PFK-2 immunotitration was 
carried out in 0.2-m] incubations containing 100 mM KCI, 
15 mM P-mercaptoethanol, 20 mM Tris, pH 8, 0.1% bovine 
serum albumin, 75 pl of protein A-Sepharose suspension (l/l), 
a fixed volume of cytosol or PEG extract and up to 50 ,xI of an- 
tiserum. After 30 min of agitation at room temperature, the im- 
mune complexes were precipitated (8000 x g, 4 min) and the 
residual PFK-2 activity was measured in the supernate. 
3. RESULTS AND DISCUSSION 
3.1. Changes in PFK-2 enzyme content 
As expected from earlier work [3-61, liver 
PFK-2 activity in starved and in diabetic rats fell to 
about 50% of the values for fed rats (table 1). We 
therefore determined by immunotitration whether 
this resulted from a decreased liver content of 
PFK-2. As shown in fig.lA and table 1, the dif- 
ferences in immunoprecipitable PFK-2 content 
were commensurate with the differences in PFK-2 
activities between fed and starved or diabetic rats. 
These differences were not due to a greater effi- 
ciency of the antibody in recognizing the 
phosphorylated form of PFK-2. Indeed, the im- 
Table 1 
Liver PFK-2 activity, content, and relative mRNA levels 
Activitya 
+U/mg protein) 
Contentb 
011) 
Relative mRNA levels’ 
Expt A Expt B Exnt C 
Control (fed) 61 +I 5 (11) 3.39 + 0.25 (9) 12.8 + 1.2 (11) 
25 * 2 (lO)d 
13.5 k 3.8 (3) 
1.66 * 0.28 (5)d 
4.9 + 0.5 (9) 
Starved (72 h) 15.1 + 1.4 (8) ND 5.3 t 1.0 (8) 
Diabetic (alloxan) 37 + 2 (5)d 1.55 f 0.29 (6)d 17.0 t 4.4 (5) 15.8 * 2.5 (5) ND 
Diabetic (STZ) 24 + 4 (6)d 2.45 + 0.87 (3) ND ND ND 
a PFK-2 activity was measured on cytosol at pH 8.5 except for streptozotocin-treated rats for which the activity was 
measured at pH 7.1 on a PEG extract 
b Volume of BCL-2 antiserum required to precipitate 50% of PFK-2 activity in the presence of protein A-Sepharose, 
calculated from logit plots of immunotitration curves such as those in fig.lA 
’ For each RNA sample, the slope of the linear relationship (see fig.2) between amount of radioactivity hybridized and 
quantity of RNA spotted was calculated for the PFK-2 cDNA probe and for the actin cDNA probe. The ratio (x lo*) 
of these slopes gives the units shown. The PFK-2 cDNA probes were as follows: Expt A, probe RL2K-8; Expt B, probe 
RL2K-22~2; Expt C, probe RL2K-4~3. Data in each column are not expected to match those in other columns because 
of differences in specific radioactivity of the probes between experimental series 
d p < 0.01 vs controls by non-paired r-test 
The values are means & SE for the number of animals given in parentheses. STZ, streptozotocin; ND, not determined 
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Fig.1. lmmunotitration of liver PFK-2. Enzyme activity was measured at pH 8.5 after immunoprecipitation. All incubations contained 
1.5 mg of cytosolic protein/ml. (A) Effect of starvation or diabetes. Total PFK-2 activity was 75 pIJ/mg protein in the control (open 
symbols), 28 yU/mg in the starved (m), and 37 pU/mg in the alloxan-diabetic (A) rat. All incubations contained protein A-Sepharose 
and BCL-2 antiserum except for (0) which contained no protein A-Sepharose and for (A) in which BCL-2 antiserum was replaced 
by nonimmune serum. (B) Immunotitration of PFK-2 from fed rats injected (m) or not (0) in the portal vein with 0.5 ml glucagon 
(10e6 M) 5 min before being killed. PFK-2 activity was 65 and 60 at pH 8.5, and 88 and 40 pU/mg protein at pH 6.6 for control and 
glucagon-treated rats, respectively. 
munotitration curve of phosphorylated PFK-2 (ob- 
tained from a glucagon-treated rat) was 
superimposable to that of a fed rat (fig. 1B). Since, 
in the absence of protein A-Sepharose, BCL-2 an- 
tiserum did not influence liver PFK-2 activity from 
control (fig.lA) or treated (not shown) rats, the 
shift in the immunotitration curves seen in fig.lA 
did not result from PFK-2 activation or inhibition 
by antiserum [17]. 
3.2. Lack of change in PFK-2 mRNA content 
The data presented above suggest that the 
decreased PFK-2 activity in the liver of starved and 
of diabetic rats results from a decreased enzyme 
content rather than from a change in catalytic ac- 
tivity, e.g. by covalent modification. One possible 
mechanism is a decreased steady-state level of 
PFK-2 mRNA. Northern blot analysis of total or 
poly(A)+ liver RNA, hybridized with the RL2K-8 
cDNA probe, revealed one band corresponding to 
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a mRNA of about 2150 nucleotides. This suggests 
that liver PFK-2 mRNA precursors are very large 
and therefore do not migrate into the gel or do not 
transfer adequately onto the nitrocellulose filters. 
PFK-2 mRNA was quantitated in dot blot ex- 
periments by measuring the intensity of hybridiza- 
tion calculated from the slope of the linear 
relationship between radioactivity in the blots and 
quantity of RNA spotted (fig.2). The data were 
then normalized by reference to the slope for actin 
mRNA in the same sample (table 1). The PFK-2 
mRNA content determined with the three PFK-2 
cDNA probes was the same in control and treated 
rats (table 1). To confirm the significance of these 
results, liver RNA from all experimental groups 
was hybridized with a cDNA probe specific for 
pyruvate kinase mRNA. As expected [181, the liver 
content of this mRNA decreased to about 50% of 
control values in fasted (fig.3) and in diabetic rats. 
Thus, had such variations in PFK-2 mRNA taken 
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Fig.2. Dot blot hybridization of total liver mRNA with PFK-2, actin and pyruvate kinase (PK) cDNA probes. The graph was obtained 
by plotting the radioactivity of the spots shown. 
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Fig.3. Effect of starvation on the relationship between enzyme activity and mRNA content in individual livers. Units of mRNA levels 
were calculated as in table 1. The PFK-2 cDNA probe was RL2K-8. 
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place, the method was sensitive enough to detect 
them. The data in fig.3 support this conclusion. 
When the liver PFK-2 mRNA content of individual 
rats was matched to liver PFK-2 activity of the 
same sample, a linear relationship was obtained, 
with a steeper slope for control than for starved 
rats. In contrast, although a linear relationship was 
also obtained, the slopes did not differ when 
pyruvate kinase mRNA content was compared to 
pyruvate kinase activity. 
Taken together, the data suggest that the 
decrease in liver PFK-2 content demonstrated here 
in starved and in diabetic rats results from a post- 
transcriptional control mechanism exerted beyond 
mRNA synthesis or degradation. Conceivably, this 
could involve decreased translational efficiency 
[19-211 of an unchanged amount of PFK-2 
mRNA, or increased turnover of the PFK-2 pro- 
tein, or both. 
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